Table 2.
Prognosis associated with renal manifestations.
| Mortality—pooled odds ratio % (95% CI)/n | Critical presentation—pooled odds ratio % (95% CI)/n | |
|---|---|---|
| Acute kidney injury | 9.03 (5.45–14.94) 16 studies/11,948 patients |
17.58 (10.51–29.38) 10 studies/7,934 patients |
| Stage 1 | 7.45 (2.98–18.67) three studies/6,373 patients |
N/A |
| Stage 2 | 24.64 (2.37–255.78) two studies/5,782 patients |
N/A |
| Stage 3 | 94.77 (10.25–876.37) three studies/6,373 patients |
N/A |
| Renal replacement therapy | 19.69 (4.53–85.70) 10 studies/4,563 patients |
34.98 (15.17–80.68) 10 studies/18,437 patients |
Patients with renal replacement therapy history were excluded. Pooled odds ratio (by random effect model) of mortality and critical presentation with acute kidney injury. Critical presentation was defined as intensive care admission.